Funding Opportunity: Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01/R21) (R01) (R21)


To efficiently use the existing cancer registry infrastructure by augmenting data already collected with additional information needed to understand health disparities among people diagnosed with cancer.

Research Areas — may include, but are not limited to:

  1. Understanding why some populations are less likely to receive recommended treatment.
  2. Assessing the prognostic and predictive value of specific biomarkers in cancer incidence, progression, and treatment.
  3. Understanding the role of behavior/lifestyle factors on recurrence and survival after diagnosis.
  4. Impact of socioeconomic status and location of residence on treatment received.
  5. Urban/rural differences.
  6. Role of cultural environment and social support on cancer outcomes.
  7. Role of mode of detection (screening versus clinical detection) on differences in severity of disease at diagnosis and survival outcomes.

Funding Instrument

R01 Research Project Grant
R21 Exploratory/Developmental Grant

Award Project Period

R01—The scope of the proposed project should determine the project period. The maximum project period is 5 years.
R21—up to 2 years.

Award Budget

R01—Application budgets are not limited but need to reflect the actual needs of the proposed project.
R21—The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.


U.S institutions
Foreign components are allowed, as defined in the NIH Grants Policy Statement
(Non-U.S. institutions and non-U.S. components of U.S. organizations are not eligible to apply.)


Kathleen Cronin, PhD
National Cancer Institute
Telephone: 240-276-6836

Nadia Howlader, PhD, MS
National Cancer Institute
Telephone: 240-276-6891

Earliest Submission Date

R01—September 5, 2017
R21—September 16, 2017